이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Videocapillaroscopic Findings in Hand Osteoarthritis

2026년 11월 11일 업데이트: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

Association of Nailfold Videocapillaroscopy Findings With Clinical, Functional, and Radiological Characteristics in Primary Hand Osteoarthritis: A Comparative Cross-Sectional Study With Healthy Controls

The purpose of this study is to compare microvascular changes-assessed via nailfold videocapillaroscopy-in patients with primary hand osteoarthritis against a healthy control group, and to investigate the relationship between capillaroscopic findings and disease severity, functional status, and clinical characteristics.

연구 개요

상태

아직 모집하지 않음

상세 설명

In this context, the associations between capillaroscopic parameters and the Kellgren-Lawrence radiological grading, handgrip strength, the Functional Index for Hand Osteoarthritis (FIHOA), and the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) scores will be evaluated. Furthermore, the study aims to determine the potential clinical value of nailfold videocapillaroscopy in identifying microvascular alterations associated with primary hand osteoarthritis.

연구 유형

관찰

등록 (추정된)

130

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

  • 이름: Ayşegül ÖZDOĞAN BİRCAN, Specialist Physician

연구 장소

    • Balıkesir
      • Bandırma, Balıkesir, 터키 (Türkiye), 10200
        • Bandırma Onyedi Eylul University Faculty of Medicine
        • 연락하다:
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

샘플링 방법

확률 샘플

연구 인구

The study population will consist of patients diagnosed with primary hand osteoarthritis and age- and sex-matched healthy controls. Participants will undergo clinical assessment, hand function evaluation, radiographic assessment, and nailfold videocapillaroscopy.

설명

Inclusion Criteria:

  • Patient group (Primary hand osteoarthritis)

    • Being 18 years of age or older.
    • Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations.
    • Being willing to participate in the study and having signed the written Informed Consent Form.
    • Being able to undergo clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations.
    • Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.

Healthy control group

  • Being 18 years of age or older.
  • Having no diagnosis of inflammatory rheumatologic disease or primary hand osteoarthritis.
  • Being willing to participate in the study and having signed the written Informed Consent Form.
  • Being similar to the patient group in terms of age and gender.
  • Being able to undergo nailfold videocapillaroscopy assessment.

Exclusion Criteria:

  • Patient group

    • Being under 18 years of age.
    • Diagnosis of secondary osteoarthritis of the hand (due to trauma, infection, metabolic, or other causes).
    • Presence of rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, inflammatory myopathies, vasculitis, or other connective tissue diseases.
    • History of Raynaud's phenomenon.
    • History of malignancy.
    • Chronic renal failure (stage 4-5) or advanced liver failure.
    • Active infection or a serious infection within the last four weeks.
    • Pregnancy or breastfeeding.
    • History of a neurological condition that could affect hand grip strength (e.g., hemiplegia, tetraplegia, peripheral nerve injury, or other neurological/neuromuscular disorders resulting in loss of muscle strength).
    • History of trauma, surgical intervention, or any procedure affecting the nail bed of the fingers within the last month.
    • Presence of an open wound, active infection, severe dermatological condition, or deformity that would hinder the assessment of the nail fold.
    • Refusal to participate in the study or failure to sign the informed consent form.

Healthy control group

In addition to the exclusion criteria listed above:

  • Diagnosis of primary osteoarthritis of the hand or any inflammatory rheumatic disease.
  • Presence of hand pain or any chronic musculoskeletal disorder that affects hand function.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: CASE_CONTROL
  • 시간 관점: CROSS_SECTIONAL

코호트 및 개입

그룹/코호트
hand osteoarthritis group

hand osteoarthritis group;

  • Being 18 years of age or older.
  • Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations.
  • Being willing to participate in the study and having signed the written Informed Consent Form.
  • Being capable of undergoing clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations.
  • Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.
control group

control group;

  • Being 18 years of age or older.
  • Absence of a diagnosis of inflammatory rheumatic disease or primary osteoarthritis of the hand.
  • Willingness to participate in the study and having signed the written Informed Consent Form.
  • Having characteristics similar to the patient group in terms of age and gender.
  • Being able to undergo the nailfold videocapillaroscopy assessment.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Nailfold videocapillaroscopic microvascular parameters
기간: 6 months

The primary outcome is the comparison of nailfold videocapillaroscopic microvascular parameters between patients with primary hand osteoarthritis and healthy controls.

Nailfold videocapillaroscopy will be performed using the Dino-Lite Capillary Scope Pro200 digital microscope and DinoCapture v2.0 software. Prior to the examination, participants will be required to rest for at least 15 minutes in a room maintained at a constant temperature of 20-22°C; they will also be instructed to refrain from smoking or consuming caffeine for at least 30 minutes before the procedure. Participants will be questioned regarding any recent manicures, nail-biting, local trauma, or other procedures that might affect the nail bed. During the examination, the hands will be kept at the level of the heart, and immersion oil will be applied to the nailfold. The second through fifth digits of both hands will be evaluated at ×200 magnification, and images of two 1 mm areas from each digit will be recorded.

6 months

2차 결과 측정

결과 측정
측정값 설명
기간
Kellgren-Lawrence classification
기간: 6 months

Participants' hand radiographs will be evaluated for signs of osteoarthritis. The presence of osteophytes, joint space narrowing, subchondral sclerosis, cystic changes, and deformities in the distal interphalangeal, proximal interphalangeal, and first carpometacarpal joints will be recorded. The radiological severity of the disease will be graded from 0 to 4 for each joint using the Kellgren-Lawrence classification: grade 0, no radiological evidence of osteoarthritis; grade 1, questionable joint space narrowing and possible osteophytes; grade 2, definite osteophytes and possible joint space narrowing; grade 3, multiple osteophytes, definite joint space narrowing, sclerosis, and possible bone contour deformity; and grade 4, severe joint space loss, large osteophytes, marked sclerosis, and bone deformity. Radiographic hand osteoarthritis will be defined, in general, as a Kellgren-Lawrence grade of ≥2.

6 months
Australian/Canadian Osteoarthritis Hand Index (AUSCAN)
기간: 6 months

Disease-related pain, stiffness, and functional impairment will be assessed using the Australian/Canadian Osteoarthritis Hand Index (AUSCAN). AUSCAN is a 15-item, patient-reported outcome measure developed for hand osteoarthritis, comprising subscales for pain (5 items), morning stiffness (1 item), and physical function (9 items). The function subscale evaluates difficulty with activities of daily living, such as turning on a faucet, operating a doorknob, buttoning clothes, opening a jar, carrying heavy objects, and grasping small items. The scale can be administered using Likert, visual analog, or numerical rating formats; the specific version and scoring method to be used in this study will be standardized in advance. Higher scores indicate more severe symptoms and greater loss of function.

6 months
Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index)
기간: 6 months

Functional impairment due to hand osteoarthritis will also be assessed using the Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index). The FIHOA is a 10-item scale that evaluates daily hand functions, such as using a key, cutting with a knife, opening a bottle or jar, buttoning, writing, lifting objects, and shaking hands. Each item is scored on a scale of 0-3, with a total score ranging from 0-30; a higher score indicates greater functional impairment. The validity and reliability of the Turkish version of the FIHOA have been established, and it has been reported to demonstrate high internal consistency and test-retest reliability.

6 months
Handgrip strength
기간: 6 months

Grip strength will be measured separately for each hand using a standard hand dynamometer (Baseline brand, 200 lb LITE hydraulic hand dynamometer). During the measurement, the participant will be in a seated position, with the shoulder in adduction and neutral rotation, the elbow flexed at approximately 90°, the forearm in a neutral position, and the wrist in slight extension. Three measurements will be taken for each hand, with short rest intervals between them; the analysis will utilize either the mean of these measurements or the highest value, in accordance with a pre-established protocol. The brand and model of the dynamometer used will be specified in the research form. Grip strength measurements obtained via a hand dynamometer have been shown to be reliable in patients with hand osteoarthritis.

6 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 20일

기본 완료 (추정된)

2027년 4월 20일

연구 완료 (추정된)

2027년 4월 30일

연구 등록 날짜

최초 제출

2026년 11월 11일

QC 기준을 충족하는 최초 제출

2026년 11월 11일

처음 게시됨 (실제)

2026년 11월 17일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 11일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • E-67961857-050.04-2600065387

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Individual participant data (IPD) will not be shared with other researchers due to patient confidentiality and data privacy considerations. Only anonymized aggregate data may be reported in the publication.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다